[1]李宇思,刘 艺,李会敏,等.基于“因加而发”探讨甲状腺结节“结癌转化”防治[J].陕西中医,2024,(5):658-661.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.019]
 LI Yusi,LIU Yi,LI Huimin,et al.Discussing the prevention and treatment of thyroid nodules nodule-cancer transformation transformation by view of traditional Chinese medicine “disease due to addition”[J].,2024,(5):658-661.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.019]
点击复制

基于“因加而发”探讨甲状腺结节“结癌转化”防治
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年5期
页码:
658-661
栏目:
学术探讨
出版日期:
2024-05-05

文章信息/Info

Title:
Discussing the prevention and treatment of thyroid nodules nodule-cancer transformation transformation by view of traditional Chinese medicine “disease due to addition”
作者:
李宇思1刘 艺1 李会敏1 任 静2 魏军平1
(1.中国中医科学院广安门医院,北京 100053; 2.北京中医药大学,北京 100053)
Author(s):
LI YusiLIU YiLI HuiminREN JingWEI Junping
(Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)
关键词:
甲状腺结节 因加而发 结癌转化 病机 治未病 防治
Keywords:
Thyroid nodules Disease due to addition Nodule-cancer transformation Pathogenesis Treating diseases before they occur Prevention and treatment
分类号:
R 581.3
DOI:
DOI:10.3969/j.issn.1000-7369.2024.05.019
文献标志码:
A
摘要:
甲状腺结节可归于中医学“瘿病”“瘿瘤”等范畴,其基本病机为正气虚损,邪毒瘀滞。究甲状腺结节结癌转化之变,实为本元亏虚的基础上,新邪惑乱诱发痰凝、气滞、血瘀、毒结等故邪作祟,结聚颈前,破坏正邪平衡,正气无力驱邪外出,久羁为患,变生癌浊,日久发为癌瘤。“因加而发”发病理论不仅包括多因素累加导致疾病发生,亦注重邪正交互的作用,与甲状腺结节的发生发展具有相同之处。在“因加而发”理论指导下,探讨中医“治未病”的优势,将甲状腺结节治疗窗口前移,攻邪于毒未鸱张亢盛之时,扶正于正气尚未衰败之际,延缓甲状腺结节癌变进程,为临床中西医结合防治甲状腺结节结癌转化提供思路。
Abstract:
Thyroid nodules can be classified into the categories of “gall disease”“gall tumor”and other categories in traditional Chinese medicine,the basic pathogenesis is deficiency of vital energy and stagnation of pathogenic toxins.Exploring the nodule-cancer transformation,on the basis of the deficiency of the original element,the new evil causes confusion and induces phlegm coagulation,qi stagnation,blood stasis,toxin accumulation,and other pathogenic factors,disrupt the balance between good and evil,zhengqi is unable to expel evil when going out,and prolonged confinement can lead to cancer and turbidity,leading to the development of cancerous tumors over time.The theory of “Disease due to addition” not only includes the accumulation of multiple factors leading to the occurrence of the disease,but also emphasizes the interaction between evil and positive factors,which shares similarities with the occurrence and development of thyroid nodules.Under the guidance of the theory of “arising from addition”,fully utilize the advantages of traditional Chinese medicine in “treating diseases before they occur”,and move the treatment window for thyroid nodules forward.Attack the poison before the cockroach becomes overpowering,and support the righteous qi before it decays,to slow down the progression of thyroid cancer and provide ideas for the prevention and treatment of thyroid nodules nodule-cancer transformation through the combination of traditional Chinese and western medicine in clinical practice.

参考文献/References:

[1] ALEXANDER E K,CIBAS E S.Diagnosis of thyroid nodules[J].Lancet Diabetes Endocrinol,2022,10(7):533-539.
[2] LI Y,TENG D,BA J,et al.Efficacy and safety of long-term universasalt lodization on thyroid disorders:Epidemiological evidence from 31 provinces of Mainland China[J].Thyroid,2020,30(4):568-579.
[3] 范晔,段延萍,周杰,等.从《内》《难》经入手看“治未病”思想的源流及价值[J].陕西中医,2009,30(2):222-223.
[4] 陆王娟,周贤梅.中医体质在肺结节早期诊治中的应用探讨[J].陕西中医,2018,39(4):518-520.
[5] 田代华.灵枢经[M].北京:人民卫生出版社,2005:12,115,130.
[6] 杨上善.黄帝内经太素[M].北京:中医古籍出版社,2016:474.
[7] 马莳.黄帝内经灵枢注证发微[M].北京:学苑出版社,2007:413.
[8] 张介宾.类经[M].北京:中医古籍出版社,2016:438.
[9] 沈金鳌.杂病源流犀烛[M].北京:人民卫生出版社,2006:349.
[10] 田代华.黄帝内经素问[M].北京:人民卫生出版社,2005:1,39,118,188.
[11] 鲍林杨.《内经》“因加而发”的发病理论研究[D].济南:山东中医药大学,2018.
[12] 周嘉培,王小平.《黄帝内经》合邪发病观辨析[J].中华中医药杂志,2021,36(9):5233-5236.
[13] 任静,高云逸,李宇思,等.基于“木郁达之”探讨甲状腺结节病机及风药的应用[J].陕西中医,2023,44(8):1090-1093.
[14] 陈实功.外科正宗[M].北京:人民卫生出版社,2007:139-140.
[15] 王焘.外台秘要[M].北京:中国医药科技出版社,2011:382.
[16] 陈金凤,谭韵仪,陈日聪,等.基于伏邪理论探讨甲状腺结节因机证治[J].福建中医药,2023,54(7):42-45.
[17] 严用和.重辑严氏济生方[M].北京:中国医药科技出版社,2007:173.
[18] 仇莲胤,阙华发.甲状腺结节辨证分型标准的临床研究[J].上海中医药大学学报,2013,27(4):26-30.
[19] 郭晨阳.“治未病”观下甲状腺结节的现代防治思路研究[D].成都:成都中医药大学,2020.
[20] 黄永生,郭家娟,邓悦,等.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志,2007,21(6):3-4.
[21] 肖贤,王晓群,赵林林,等.贾英杰运用黜浊五法论治肿瘤经验[J].中医杂志,2022,63(1):12-16.
[22] 花娇娇,耿晓桐,刘琦.猫爪草化学成分及药理作用研究进展综述[J].品牌与标准化,2023,45(3):112-114.
[23] 刘颖.李小娟教授治疗甲状腺结节用药规律及网络药理学研究[D].沈阳:辽宁中医药大学,2023.
[24] 鲁明源.《内经》治未病的理论内涵及实践价值[J].中医药信息,2008,25(5):5-6.
[25] 中国抗癌协会甲状腺癌专业委员会.中国抗癌协会甲状腺癌整合诊治指南(2022精简版)[J].中国肿瘤临床,2023,50(7):325-330.
[26] 李朋,韦伟.美国国家综合癌症网络甲状腺恶性肿瘤治疗指南(2020V1)解读[J].临床外科杂志,2021,29(1):32-35.
[27] 任传伟,张安文.2569 例结节性甲状腺肿的临床病理与发病情况分析[J].空军医学杂志,2019,35(3):222-224.
[28] 高瑞雲,王宽宇.夏枯草及其有效成分抗甲状腺癌作用机制的研究概述[J].中国中医药科技,2023,30(6):1247-1249.
[29] 王骁,范焕芳,李德辉,等.山慈菇抗肿瘤作用研究进展[J].江苏中医药,2023,55(2):74-76.
[30] LIU Z,ZHONG L,WANG L,et al.Integrating network pharmacology and experimental studies for uncovering the molecular mechanisms of Dioscorea bulbifera L.in the treatment of thyroid cancer[J].Heliyon,2023,9(8):e18886.
[31] 李悦,黄菁,陈婷,等.中药干预肿瘤微环境中免疫细胞的研究进展[J].世界中医药,2023,18(4):566-571.

相似文献/References:

[1]李 冉,任继鹏,范会军,等.八珍汤在甲状腺结节细针穿刺术后的应用价值[J].陕西中医,2019,(6):777.
 LI Ran,REN Jipeng,FAN Huijun,et al.Application value of Bazhen decoction after thyroid nodule needle puncture[J].,2019,(5):777.
[2]刘颖洁,王小平,张 宇,等.消瘿方凝胶治疗消融术后甲状腺结节疗效研究*[J].陕西中医,2019,(9):1241.
[3]郅扶旻,孙士博,徐洪涛,等.玄夏消瘿汤治疗痰结血瘀型甲状腺结节疗效及对患者甲状腺超声指标及评分的影响[J].陕西中医,2023,(5):604.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.014]
[4]任 静,高云逸,李宇思,等.基于“木郁达之”探讨甲状腺结节病机及风药的应用[J].陕西中医,2023,(8):1090.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.021]
 REN Jing,GAO Yunyi,LI Yusi,et al.Discussion on the pathogenesis of thyroid nodules and the application of wind medicine based on “Muyu Dazhi”[J].,2023,(5):1090.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.021]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81573961); 首都卫生发展科研专项-自主创新课题(首发2020-2-4154); 中国中医科学院中央级公益性科研院所基本科研业务费业务专项(ZZ11-030,ZZ15-XY-PT-13)
更新日期/Last Update: 2024-05-09